Last reviewed · How we verify
Placebo of TQC2731 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of TQC2731 (Placebo of TQC2731) — Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.. This is a placebo control arm and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of TQC2731 TARGET | Placebo of TQC2731 | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of TQC2731 CI watch — RSS
- Placebo of TQC2731 CI watch — Atom
- Placebo of TQC2731 CI watch — JSON
- Placebo of TQC2731 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of TQC2731 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-tqc2731. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab